About Jeanine Wiener-Kronish, MD

Research interests: Pseudomonas aeruginosa lung infections, the molecular identification of bacteria, bacterial communities and their effect on lung infections. The use of electrical impedance tomography and esophageal manometry for adjusting mechanical ventilation settings in the ICU and in the OR. The use of remote monitoring to improve perioperative patient outcomes.

Departments, Centers, & Programs:

Clinical Interests:



Anesthesia, Critical Care and Pain Medicine
55 Fruit Street
Boston, MA 02114-2696
Phone: 617-724-3257
Fax: 617-726-3032

Medical Education

  • MD, UC San Francisco School of Medicine
  • Residency, Mount Zion Hospital & Medical Center
  • Residency, UC San Francisco
  • Fellowship, UC San Francisco

American Board Certifications

  • Pulmonary Disease, American Board of Internal Medicine
  • Critical Care Medicine, American Board of Internal Medicine
  • Internal Medicine, American Board of Internal Medicine
  • Anesthesiology, American Board of Anesthesiology

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Dr. Wiener-Kronish has devoted much of her academic career to investigating the mechanism of acute lung injury produced by Pseudomonas aeruginosa, a gram negative bacterium that can infect patients in the intensive care unit. Her past research focused on the mechanism of pleural fluid formation during acute lung injury, how toxins produced by Pseudomonascause acute lung injury, and the production of humanized antibodies that will block these products. Most recently, she has investigated the epidemiology of bacterial communities in asthmatics, critically ill patients and in young, newly colonized patients with cystic fibrosis. The goal of her research is to establish whether there are beneficial communities of bacteria that protect patients against asthma and infections. Dr. Wiener-Kronish is working with oral biologists and environmental scientists to utilize molecular identification of bacteria for these investigations.